Did you know that Belgium is a vibrant and innovative ecosystem in health and life sciences? 

Belgium is serving as a covid vaccine production powerhouse to fight the pandemic. The Belgian biopharma industry has been the leader for the European market for the 5th year in a row.

Top Belgian life sciences companies will host a full-day event at the MassBio Hub on June 10^th with the aim to meet and engage US companies and to develop partnerships. This event is taking place within the biggest Belgian trade mission ever organized, chaired by HRH Princess Astrid, with a delegation of more than 250 companies.

It will be an opportunity to learn, meet and network with CEOs of established and promising life science companies. (http://www.investinwallonia.be/key-sectors/life-sciences/belgian-economic-mission-life-sciences-usa?organization=3&application=#card-9 )

The program includes conferences, seminars and B2B meetings, and, will end with a pre-Bio networking drink.

The day will be divided in 4 different sessions 

• Session 1: Biomanufacturing in Belgium – an ecosystem that goes beyond the current assets

• • • Panel discussion 1 – Health challenges of today and tomorrow: the importance of biomanufacturing capabilities – 35 min with US/BE representatives of Mithra, Kaneka-Eurogentec, GSK, Thermo Fisher
    • Panel 2: Innovation in biomanufacturing – 35 min with US/BE representatives of UCB, Univercells, Takeda, BioWin

• Session 2: Artificial Intelligence, catalyst in Health & Life-Sciences

• • Presentations by leading researchers followed by panel discussion with US/BE representatives of IMEC, MIT, N-Side, Radiomics
• Networking lunch
• Session 3: Innovation breakthroughs for a fast-growing Life Sciences industry: an overview of Massachusetts and Belgium
  • Welcoming and overview of the Massachussetts and Belgian ecosystems (MassBIO & BioWin/flanders.bio) 
  • Break-out seminars on selected topics :  
    • Cell & Gene Therapy (Cellaion, Novadip, 2Bridge)
    • Immuno-oncology (chair: ICON plc – Iteos therapeutics, PDC Line Pharma, ATB Therapeutics, Celyad, Elmedix)
    • Vaccines innovation (GSK, Quantoom Biosciences, Mithra, Idevax)
    • Medical Technology (MintT, Spentys, Nextgenics, Omina Technologies)
  • Break-out B2Bs

• Session 4: -How industry and academia can unlock beneficial interactions with Harvard and MIT?

• • • Introduction of the Harvard-MIT Belgian Society (HMBS), Introduction of Belgian Research Fellows
      • Vesicles for therapeutic delivery of bioproducts, Harvard Medical School – Massachusetts General Hospital, Department of Neurology
      • Deep Learning for chemical reactivity prediction, MIT – Department of Chemical Engineering
      • Drug screens to target aggressive leukemia, Harvard Medical School – Massachusetts General Hospital
      • Cryo-EM as a powerful tool for cancer drug discovery, Harvard Medical School – Dana Farber Cancer Institute Department Cancer Biology
      • Regeneration at our fingertips, Harvard Medical School / Massachusetts General Hospital
      • Cardiovascular Research Center
      • G-quadruplexes in human DNA, NorthEastern University College of Science, Department of Biology

.        -Breakout Session: Synthetic Biology (MIT, KULeuven, Syngulon)

• Networking drink

We look forward to meeting you on June 10^th at MassBio Hub. The number of seats being limited we suggest you register already on the following link; https://forms.gle/Fa9UXTUXk6wLbZzV7 .